JP2009512658A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009512658A5 JP2009512658A5 JP2008535989A JP2008535989A JP2009512658A5 JP 2009512658 A5 JP2009512658 A5 JP 2009512658A5 JP 2008535989 A JP2008535989 A JP 2008535989A JP 2008535989 A JP2008535989 A JP 2008535989A JP 2009512658 A5 JP2009512658 A5 JP 2009512658A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- progestogen
- transdermal patch
- guestden
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 239000000583 progesterone congener Substances 0.000 claims 8
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 claims 3
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 claims 3
- 229940011871 estrogen Drugs 0.000 claims 3
- 239000000262 estrogen Substances 0.000 claims 3
- 229960002568 ethinylestradiol Drugs 0.000 claims 3
- 239000013543 active substance Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 claims 2
- 229940095055 progestogen systemic hormonal contraceptives Drugs 0.000 claims 2
- 230000001568 sexual effect Effects 0.000 claims 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 claims 1
- 150000001875 compounds Chemical group 0.000 claims 1
- 229960004976 desogestrel Drugs 0.000 claims 1
- RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 claims 1
- 229960005352 gestodene Drugs 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229960004400 levonorgestrel Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- JUNDJWOLDSCTFK-MTZCLOFQSA-N trimegestone Chemical compound C1CC2=CC(=O)CCC2=C2[C@@H]1[C@@H]1CC[C@@](C(=O)[C@@H](O)C)(C)[C@@]1(C)CC2 JUNDJWOLDSCTFK-MTZCLOFQSA-N 0.000 claims 1
- 229950008546 trimegestone Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005050729A DE102005050729A1 (de) | 2005-10-19 | 2005-10-19 | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| PCT/EP2006/010273 WO2007045513A1 (de) | 2005-10-19 | 2006-10-19 | Verfahren zur präventiven bedarsweisen hormonalen kontrazeption |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013197047A Division JP2014001239A (ja) | 2005-10-19 | 2013-09-24 | 予防用要求次第ホルモン避妊方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009512658A JP2009512658A (ja) | 2009-03-26 |
| JP2009512658A5 true JP2009512658A5 (enExample) | 2009-12-10 |
Family
ID=37762565
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008535989A Withdrawn JP2009512658A (ja) | 2005-10-19 | 2006-10-19 | 予防用要求次第ホルモン避妊方法 |
| JP2013197047A Withdrawn JP2014001239A (ja) | 2005-10-19 | 2013-09-24 | 予防用要求次第ホルモン避妊方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013197047A Withdrawn JP2014001239A (ja) | 2005-10-19 | 2013-09-24 | 予防用要求次第ホルモン避妊方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20080311180A1 (enExample) |
| EP (1) | EP1937275A1 (enExample) |
| JP (2) | JP2009512658A (enExample) |
| KR (1) | KR20080056774A (enExample) |
| CN (1) | CN101340915A (enExample) |
| BR (1) | BRPI0617683A2 (enExample) |
| CA (1) | CA2626567C (enExample) |
| CR (1) | CR9908A (enExample) |
| DE (1) | DE102005050729A1 (enExample) |
| EC (1) | ECSP088390A (enExample) |
| GT (1) | GT200800038A (enExample) |
| HN (1) | HN2008000621A (enExample) |
| WO (1) | WO2007045513A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201070715A1 (ru) * | 2007-12-20 | 2011-02-28 | Тева Вимен'С Хелс, Инк. | Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции |
| US20120129825A1 (en) * | 2009-04-14 | 2012-05-24 | Andre Ulmann | Method for on-demand contraception using levonorgestrel or norgestrel |
| AU2010237120B8 (en) | 2009-04-14 | 2015-11-26 | Laboratoire Hra-Pharma | Method for on-demand contraception |
| DE102010040299A1 (de) | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP2782584B1 (en) | 2011-11-23 | 2021-06-09 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP2922552A1 (de) | 2012-11-22 | 2015-09-30 | Bayer Pharma Aktiengesellschaft | Verwendung und anwendungsregime einer pharmazeutischen zusammensetzung enthaltend levonorgestrel und einen cox-inhibitor zur bedarfsweisen ("on-demand") kontrazeption |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| TN2015000511A1 (en) | 2013-05-23 | 2017-04-06 | Bayer Pharma AG | Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception |
| AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5512292A (en) * | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
| DE4229820C2 (de) * | 1992-09-07 | 1998-12-03 | Jenapharm Gmbh | Pharmazeutische Zubereitung auf Gestagen-Basis |
| DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
| ATE347894T1 (de) * | 1994-10-24 | 2007-01-15 | Schering Ag | Kompetitive progesteronantagonisten zur bedarfsorientierten weiblichen fertilitätskontrolle |
| PL353994A1 (en) * | 1999-08-31 | 2003-12-15 | Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| US7384650B2 (en) * | 1999-11-24 | 2008-06-10 | Agile Therapeutics, Inc. | Skin permeation enhancement composition for transdermal hormone delivery system |
| AU2003245252A1 (en) * | 2002-04-30 | 2003-11-17 | Fmc Corporation | Carrageenan based antimicrobial compositions |
| AU2004298930B2 (en) * | 2003-12-12 | 2009-11-26 | Bayer Intellectual Property Gmbh | Transdermal delivery system of hormones without penetration enhancers |
| UA89766C2 (en) * | 2003-12-12 | 2010-03-10 | Байер Шеринг Фарма Акциенгезельшафт | Transdermal delivery system of gestodene |
-
2005
- 2005-10-19 DE DE102005050729A patent/DE102005050729A1/de not_active Withdrawn
-
2006
- 2006-10-19 CN CNA2006800480426A patent/CN101340915A/zh active Pending
- 2006-10-19 EP EP06828860A patent/EP1937275A1/de not_active Withdrawn
- 2006-10-19 US US12/090,719 patent/US20080311180A1/en not_active Abandoned
- 2006-10-19 WO PCT/EP2006/010273 patent/WO2007045513A1/de not_active Ceased
- 2006-10-19 KR KR1020087011824A patent/KR20080056774A/ko not_active Ceased
- 2006-10-19 US US11/583,143 patent/US20070111976A1/en not_active Abandoned
- 2006-10-19 CA CA2626567A patent/CA2626567C/en not_active Expired - Fee Related
- 2006-10-19 BR BRPI0617683-6A patent/BRPI0617683A2/pt not_active IP Right Cessation
- 2006-10-19 JP JP2008535989A patent/JP2009512658A/ja not_active Withdrawn
-
2008
- 2008-04-18 GT GT200800038A patent/GT200800038A/es unknown
- 2008-04-21 EC EC2008008390A patent/ECSP088390A/es unknown
- 2008-04-21 HN HN2008000621A patent/HN2008000621A/es unknown
- 2008-04-21 CR CR9908A patent/CR9908A/es not_active Application Discontinuation
-
2012
- 2012-05-29 US US13/482,023 patent/US20130089574A1/en not_active Abandoned
-
2013
- 2013-09-24 JP JP2013197047A patent/JP2014001239A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009512658A5 (enExample) | ||
| RU2154455C2 (ru) | Чрескожные терапевтические системы, содержащие половые стероиды | |
| KR102127348B1 (ko) | 항-프로게스틴의 경질 전달을 위한 제제 및 방법 | |
| EP1390041B1 (en) | Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception | |
| JP2019163318A5 (enExample) | ||
| JP2010180236A5 (enExample) | ||
| HUT75159A (en) | Percutaneously absorbable preparation, containing 3-ketodesogestrel and 17 beta-estradiol | |
| JP2013514984A5 (enExample) | ||
| KR20060054320A (ko) | 경피 호르몬 전달 시스템: 조성물 및 방법 | |
| JP2010508275A5 (enExample) | ||
| RU2009120528A (ru) | Способы гормональной терапии возрастающими дозами в режиме пролонгированного цикла | |
| JP2008536851A5 (ja) | 女性でテストステロンおよび関連ステロイドの濃度を増加させる医薬組成物および医薬キット | |
| JP2014001239A (ja) | 予防用要求次第ホルモン避妊方法 | |
| JP2007512291A (ja) | ２種のエストロゲン及び／又はプロゲスチン組成物を含んで成る、２１〜２８日よりも長い期間にわたっての連続ホルモン処理のための医薬製剤 | |
| CA2422974A1 (en) | Medicaments based on progestins for dermal use | |
| JP2007535519A5 (enExample) | ||
| CA2624810A1 (en) | Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith | |
| JP2008540482A5 (enExample) | ||
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| WO2003018026A1 (en) | Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy | |
| MX2007013137A (es) | Regimen anticonceptivo con dosificacion de estrogeno ampliada. | |
| JPH09508911A (ja) | デソゲストレルを含有する経皮適用剤 | |
| HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
| WO1999025360A2 (en) | Progestogen-antiprogestogen regimens | |
| EP1462107B1 (en) | Method of female contraception and kit for use in such method |